BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases
  • More
    • Home
    • About Us
    • Our Sciences
      • Cell-Derived Vesicle
      • BioDrone™ Platform
      • Manufacturing
      • Intellectual Properties
    • Pipeline
    • Publications
      • Publications
      • Posters & Presentations
    • Business
      • Business Model
      • Open Innovation
    • News
      • Press Releases
BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases

Cell-derived vesicle, CDV

  • CDVs are new type of nanovesicles that can function as intercellular messengers and drug transporters, similar to extracellular vesicles (EVs) such as exosomes. 
  • Because exosomes, naturally secreted from cells, are harvested from culture medium, production is limited. In contrast, CDVs can be produced in large quantities in a rapid process through direct extrusion from various human cells.
  • The extrusion technology, a core proprietary technology of MDimune, is patented in five major countries (USA, Europe, China, Japan, and Korea).

Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

  • Contact